{"id":"daily-methadone-dose","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"nausea"},{"rate":"10-20%","effect":"dizziness"},{"rate":"5-10%","effect":"constipation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Methadone acts as an agonist at the mu-opioid receptor, providing analgesia and reducing withdrawal symptoms in opioid use disorder.","oneSentence":"opioid receptor agonist","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:31:06.983Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"opioid use disorder"},{"name":"chronic pain"}]},"trialDetails":[{"nctId":"NCT05529927","phase":"PHASE2","title":"Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Parnassia Addiction Research Centre","startDate":"2026-05","conditions":"Cocaine Use Disorder","enrollment":204},{"nctId":"NCT04145674","phase":"PHASE2","title":"A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo","status":"SUSPENDED","sponsor":"Mauro Manconi","startDate":"2022-10-22","conditions":"Restless Legs Syndrome","enrollment":50},{"nctId":"NCT05789173","phase":"EARLY_PHASE1","title":"Interaction of CYP2B6 Genotype and Efavirenz With Methadone and Tizanidine PK","status":"RECRUITING","sponsor":"Indiana University","startDate":"2023-10-06","conditions":"Drug-Drug Interaction","enrollment":60},{"nctId":"NCT05459402","phase":"PHASE2, PHASE3","title":"Divided or Single Exposure (DOSE) Study","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2023-02-21","conditions":"Opioid Use Disorder, Chronic Pain, Methadone","enrollment":150},{"nctId":"NCT00659035","phase":"","title":"Use of Driving Tests to Evaluate Patient Performance on Oral Opioids","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asokumar Buvanendran","startDate":"2008-04","conditions":"Chronic Pain","enrollment":450},{"nctId":"NCT07314346","phase":"PHASE1","title":"Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone","status":"NOT_YET_RECRUITING","sponsor":"Atea Pharmaceuticals, Inc.","startDate":"2025-12","conditions":"Healthy Volunteer Study","enrollment":32},{"nctId":"NCT05766631","phase":"PHASE3","title":"Treating Polysubstance Use Using a Novel Digital Technology","status":"RECRUITING","sponsor":"Friends Research Institute, Inc.","startDate":"2023-07-26","conditions":"Opioid Use, Opioid Use Disorder, Cocaine Use","enrollment":240},{"nctId":"NCT04345718","phase":"PHASE2, PHASE3","title":"EXHIT ENTRE Comparative Effectiveness Trial","status":"COMPLETED","sponsor":"Gavin Bart","startDate":"2021-08-09","conditions":"Substance Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe","enrollment":344},{"nctId":"NCT02025855","phase":"PHASE4","title":"Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit","status":"TERMINATED","sponsor":"Henry Ford Health System","startDate":"2014-01","conditions":"Opioid Use, Unspecified With Withdrawal, Opioid-Induced Disorders, Delirium","enrollment":9},{"nctId":"NCT03726268","phase":"PHASE4","title":"Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement)","status":"COMPLETED","sponsor":"Duke University","startDate":"2018-11-29","conditions":"Opioid Use, Pain, Postoperative","enrollment":907},{"nctId":"NCT06940570","phase":"PHASE3","title":"Methadone as an Alternative Treatment for Children Underdoing HSCT","status":"SUSPENDED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2028-01-01","conditions":"Leukemia, Aplastic Anemia, Bone Marrow Failure Syndromes","enrollment":60},{"nctId":"NCT06877858","phase":"PHASE1","title":"MethaLoad Dose-Finding Study","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-09-25","conditions":"Opioid Use Disorder (OUD)","enrollment":24},{"nctId":"NCT05212012","phase":"PHASE1, PHASE2","title":"D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"AIO-Studien-gGmbH","startDate":"2022-02-17","conditions":"Chemo-refractory Colorectal Carcinoma","enrollment":11},{"nctId":"NCT05924022","phase":"PHASE1","title":"Hyperbaric Oxygen Treatment (HBOT) During Methadone Tapering","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington State University","startDate":"2023-12-04","conditions":"Opioid Use Disorder","enrollment":36},{"nctId":"NCT05786599","phase":"PHASE2, PHASE3","title":"Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-03-21","conditions":"Chemotherapy-induced Peripheral Neuropathy","enrollment":50},{"nctId":"NCT04491968","phase":"NA","title":"Mindfulness Oriented Recovery Enhancement for Chronic Pain and Opioid Relapse","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-08-13","conditions":"Opioid Use, Chronic Pain","enrollment":154},{"nctId":"NCT05693675","phase":"PHASE2, PHASE3","title":"Postoperative Oral Methadone After Major Spine Surgery; Safety, Feasibility and Efficacy in Prevention of Progression to Chronic Opioid Usage at 3 Months","status":"WITHDRAWN","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2023-10-01","conditions":"Spine Surgery","enrollment":""},{"nctId":"NCT06735079","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)","status":"WITHDRAWN","sponsor":"MGGM LLC","startDate":"2024-12-27","conditions":"Major Depressive Disorder (MDD)","enrollment":""},{"nctId":"NCT01857245","phase":"NA","title":"Intensive Models of HCV Care for Injection Drug Users","status":"COMPLETED","sponsor":"Prisma Health-Upstate","startDate":"2013-10-01","conditions":"Hepatitis C, Medication Adherence","enrollment":150},{"nctId":"NCT04568603","phase":"PHASE1","title":"Islatravir and Methadone Pharmacokinetics (MK-8591-029)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-10-16","conditions":"HIV-1 Infection","enrollment":14},{"nctId":"NCT04764825","phase":"PHASE4","title":"Methadone for Spinal Fusion Surgery.","status":"TERMINATED","sponsor":"University of Aarhus","startDate":"2021-02-26","conditions":"Pain, Postoperative, Back Pain, Opioid Use","enrollment":114},{"nctId":"NCT03365362","phase":"PHASE4","title":"A Trial of Directly Observed and Long-term Varenicline","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-10-25","conditions":"Tobacco Use Disorder, Opioid-use Disorder","enrollment":243},{"nctId":"NCT00930332","phase":"PHASE1","title":"Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain","status":"TERMINATED","sponsor":"NCIC Clinical Trials Group","startDate":"2010-06-17","conditions":"Nausea and Vomiting, Pain, Sleep Disorders","enrollment":8},{"nctId":"NCT03051256","phase":"PHASE2","title":"Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD","status":"COMPLETED","sponsor":"Relmada Therapeutics, Inc.","startDate":"2018-05-11","conditions":"Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant","enrollment":62},{"nctId":"NCT05998876","phase":"","title":"Assessing Dose Taken in Opioid Use Disordered Patients With an Electrochemical Sensor","status":"UNKNOWN","sponsor":"Cari Health Inc.","startDate":"2024-02","conditions":"Adherence, Medication, Opioid Use Disorder","enrollment":45},{"nctId":"NCT02851303","phase":"PHASE4","title":"Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2016-10","conditions":"Neonatal Abstinence Syndrome","enrollment":61},{"nctId":"NCT05861544","phase":"NA","title":"NUTRItion-driven Detoxification of OPioid Addicted patiEnts","status":"UNKNOWN","sponsor":"Organization Against Drugs (ΟΚΑΝΑ)","startDate":"2023-03-23","conditions":"Psychiatry","enrollment":58},{"nctId":"NCT05235191","phase":"PHASE3","title":"Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2019-09-06","conditions":"Neuropathic Pain","enrollment":80},{"nctId":"NCT05251376","phase":"PHASE1","title":"Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy","status":"WITHDRAWN","sponsor":"Lyndra Inc.","startDate":"2022-02-28","conditions":"Opioid Use Disorder, Moderate","enrollment":""},{"nctId":"NCT01936857","phase":"PHASE4","title":"Buprenorphine to Improve HIV Care Engagement and Outcomes","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2015-07","conditions":"HIV, Substance Related Disorders","enrollment":281},{"nctId":"NCT02363998","phase":"PHASE3","title":"Open-Label, Safety Study of Lofexidine","status":"COMPLETED","sponsor":"USWM, LLC (dba US WorldMeds)","startDate":"2015-02","conditions":"Opioid Withdrawal","enrollment":286},{"nctId":"NCT03894501","phase":"NA","title":"Pilot of Mindfulness Oriented Recovery Enhancement in MethadoneTreatment","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2019-01-31","conditions":"Opioid Use, Chronic Pain","enrollment":30},{"nctId":"NCT00838981","phase":"PHASE1, PHASE2","title":"Pharmacotherapy & CM for Opioid and Cocaine Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2008-05","conditions":"Cocaine Dependence","enrollment":91},{"nctId":"NCT00863057","phase":"PHASE2","title":"Combination Pain Therapy in HIV Neuropathy","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-05","conditions":"HIV Infections, Peripheral Neuropathy","enrollment":15},{"nctId":"NCT03127358","phase":"NA","title":"Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2017-11-14","conditions":"Hepatitis C, Medication Adherence","enrollment":11},{"nctId":"NCT01378858","phase":"NA","title":"Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2011-07","conditions":"Tobacco Use Disorder, Medication Adherence","enrollment":100},{"nctId":"NCT01205516","phase":"PHASE4","title":"Methadone in Neuropathic Pain","status":"TERMINATED","sponsor":"Nova Scotia Health Authority","startDate":"2013-01","conditions":"Chronic Neuropathic Pain","enrollment":14},{"nctId":"NCT03254043","phase":"NA","title":"Evaluating a Novel Medication Device for Methadone Dosing","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-01-31","conditions":"Opioid-use Disorder","enrollment":26},{"nctId":"NCT00292110","phase":"PHASE1","title":"Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2004-02-01","conditions":"Opiate-Related Disorders, Cocaine-Related Disorders","enrollment":140},{"nctId":"NCT01958476","phase":"PHASE3","title":"Improving Outcomes in Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2013-09","conditions":"Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal","enrollment":117},{"nctId":"NCT02715700","phase":"PHASE1","title":"Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-09-28","conditions":"Human Immunodeficiency Virus (HIV) Infection","enrollment":14},{"nctId":"NCT00420771","phase":"PHASE2","title":"Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2007-01","conditions":"Benzodiazepine Dependence, Opioid Dependence","enrollment":19},{"nctId":"NCT00809835","phase":"PHASE2","title":"Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-12","conditions":"Cocaine Dependence","enrollment":120},{"nctId":"NCT03436225","phase":"PHASE1","title":"Steroid Therapy in Acute Bronchiolitis A New Old Line of Therapy.","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-02","conditions":"Bronchiolitis; Respiratory Syncytial Virus","enrollment":80},{"nctId":"NCT02147132","phase":"PHASE4","title":"Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients","status":"TERMINATED","sponsor":"University of Cincinnati","startDate":"2016-03","conditions":"Cigarette Smoking, Methadone Maintenance","enrollment":7},{"nctId":"NCT00218036","phase":"PHASE2","title":"Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2006-07","conditions":"Cocaine Abuse, Opiate Dependence","enrollment":54},{"nctId":"NCT01142986","phase":"NA","title":"Evaluating Three Methods for Helping Syringe Exchangers Begin Methadone Maintenance","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2010-07","conditions":"Substance Abuse Disorder","enrollment":223},{"nctId":"NCT00790569","phase":"NA","title":"Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking","status":"COMPLETED","sponsor":"Butler Hospital","startDate":"2008-09","conditions":"Bladder Cancer, Cervical Cancer, Esophageal Cancer","enrollment":315},{"nctId":"NCT01558934","phase":"PHASE1","title":"Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients","status":"COMPLETED","sponsor":"USWM, LLC (dba US WorldMeds)","startDate":"2012-02","conditions":"Opioid Dependence, Methadone Withdrawal Syndrome","enrollment":6},{"nctId":"NCT00577005","phase":"PHASE2","title":"Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-07","conditions":"Cocaine Dependence, Opioid Dependency","enrollment":28},{"nctId":"NCT01416584","phase":"NA","title":"A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2008-10","conditions":"Opiate Dependence","enrollment":98},{"nctId":"NCT01650649","phase":"PHASE1","title":"Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients","status":"COMPLETED","sponsor":"USWM, LLC (dba US WorldMeds)","startDate":"2012-07","conditions":"Opioid Dependence, Methadone Withdrawal Syndrome","enrollment":27},{"nctId":"NCT00149630","phase":"PHASE2","title":"Pharmacogenetics of Disulfiram for Cocaine","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2005-01","conditions":"Cocaine Dependence, Opioid Dependence","enrollment":93},{"nctId":"NCT01821430","phase":"PHASE2","title":"Increased Sensitivity to Pain Caused by Opioids in People Who Have Abused Prescription Opioids","status":"TERMINATED","sponsor":"Georgetown University","startDate":"2013-03","conditions":"Chronic Pain","enrollment":4},{"nctId":"NCT00129298","phase":"PHASE2","title":"Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2004-12","conditions":"Cocaine-Related Disorders, Opiate Dependence","enrollment":80},{"nctId":"NCT00218374","phase":"NA","title":"Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2006-10","conditions":"Hyperalgesia, Opioid-Related Disorders","enrollment":60},{"nctId":"NCT00593125","phase":"PHASE2","title":"Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients.","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-01","conditions":"Cocaine Dependence, Opioid Dependence","enrollment":15},{"nctId":"NCT00135759","phase":"PHASE2","title":"Addition of Naltrexone to Methadone Taper","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2005-04","conditions":"Heroin Dependence, Opioid-Related Disorders, Substance-Related Disorders","enrollment":174},{"nctId":"NCT00218127","phase":"PHASE2","title":"Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2001-11","conditions":"Heroin Dependence, Opioid-Related Disorders","enrollment":142},{"nctId":"NCT00315341","phase":"PHASE4","title":"Starting Treatment With Agonist Replacement Therapies (START)","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2006-04","conditions":"Opiate-related Disorders","enrollment":1269},{"nctId":"NCT01802515","phase":"NA","title":"A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment","status":"TERMINATED","sponsor":"Yale University","startDate":"2012-12","conditions":"Cocaine Dependence, Opiate Dependence","enrollment":14},{"nctId":"NCT01389544","phase":"PHASE1","title":"A Study on the Interaction Between Danoprevir/Ritonavir and Methadone","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-06","conditions":"Healthy Volunteer","enrollment":18},{"nctId":"NCT02687347","phase":"PHASE3","title":"Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain","status":"UNKNOWN","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2016-02","conditions":"Pain, Intractable","enrollment":204},{"nctId":"NCT01131273","phase":"PHASE3","title":"HIV Risk Reduction in Subutex Injectors in Tbilisi","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-06","conditions":"HIV","enrollment":68},{"nctId":"NCT01360463","phase":"PHASE2","title":"Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta, Indonesia","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2009-05","conditions":"HIV Risk Behaviors, Heroin Injection, Retention in Methadone Treatment","enrollment":276},{"nctId":"NCT00588640","phase":"PHASE1, PHASE2","title":"Study of D-Methadone in Patients With Chronic Pain","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2004-10","conditions":"Pain, Bladder Cancer, Breast Cancer","enrollment":10},{"nctId":"NCT02391571","phase":"PHASE3","title":"A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects","status":"COMPLETED","sponsor":"Elite Laboratories, Inc","startDate":"2015-02","conditions":"Withdrawal Symptoms","enrollment":26},{"nctId":"NCT00634010","phase":"PHASE3","title":"Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2008-02","conditions":"Advanced Cancer, Solid Tumors","enrollment":36},{"nctId":"NCT00558870","phase":"PHASE2","title":"Role of Methadone As Co-Opioid Analgesic","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2007-11","conditions":"Pain","enrollment":5},{"nctId":"NCT00087594","phase":"PHASE4","title":"A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2003-11","conditions":"Hepatitis C, Chronic","enrollment":48},{"nctId":"NCT01637922","phase":"PHASE1","title":"Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2012-08","conditions":"Hepatitis C","enrollment":34},{"nctId":"NCT01317589","phase":"PHASE4","title":"Treatment of Pain in Head-and-Neck Cancer Patients: is Methadone More Effective?","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2011-05","conditions":"Pain, Cancer of Head and Neck","enrollment":134},{"nctId":"NCT01442311","phase":"NA","title":"Directly Observed Hepatitis C Treatment in Methadone Clinics","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2007-10","conditions":"Hepatitis C, Medication Adherence","enrollment":80},{"nctId":"NCT02335398","phase":"PHASE4","title":"Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2011-07","conditions":"Pain, Chronic","enrollment":34},{"nctId":"NCT01560221","phase":"PHASE1","title":"Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-10","conditions":"Substance-related Disorders, HIV Risk Behavior","enrollment":38},{"nctId":"NCT00175357","phase":"PHASE3","title":"NAOMI: A Study to Compare Medically-prescribed Heroin With Oral Methadone in Chronic Opiate Addiction","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2005-03","conditions":"Opiate Addiction","enrollment":192},{"nctId":"NCT02245451","phase":"PHASE1","title":"Study of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Methadone Administered in Healthy Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2005-01","conditions":"Healthy","enrollment":15},{"nctId":"NCT02045693","phase":"PHASE1","title":"Drug Interaction & Methadone & Buprenorphine","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2014-02","conditions":"Hepatitis C","enrollment":32},{"nctId":"NCT00142935","phase":"NA","title":"Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1","status":"COMPLETED","sponsor":"The Miriam Hospital","startDate":"2006-09","conditions":"HIV Prevention, Opioid-Related Disorders","enrollment":87},{"nctId":"NCT01913418","phase":"PHASE2","title":"Clinical Efficacy and Serum Proteomic Profiling of Suan-Zao-Ren Tang for Sleep Disturbance During Methadone Maintenance","status":"COMPLETED","sponsor":"China Medical University, Taiwan","startDate":"2013-07","conditions":"Opiate Dependence","enrollment":90},{"nctId":"NCT01723722","phase":"PHASE4","title":"Treatment of Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"Eastern Maine Medical Center","startDate":"2007-01","conditions":"Neonatal Abstinence Syndrome","enrollment":40},{"nctId":"NCT00915564","phase":"PHASE1","title":"A Study to Investigate the Potential Pharmacokinetic Interaction Between TMC435 and Methadone","status":"COMPLETED","sponsor":"Tibotec Pharmaceuticals, Ireland","startDate":"2009-09","conditions":"Hepatitis C","enrollment":13},{"nctId":"NCT01160432","phase":"NA","title":"Naloxone Methadone Combination (NAMEKO)","status":"WITHDRAWN","sponsor":"Kuopio University Hospital","startDate":"2013-05","conditions":"Opiate Dependence","enrollment":""},{"nctId":"NCT00668265","phase":"PHASE4","title":"Anxiety in Recovering Opiate Dependence","status":"TERMINATED","sponsor":"Beth Israel Medical Center","startDate":"2008-01","conditions":"Generalized Anxiety Disorder, Comorbid Opiate Dependence in Remission, Status Post Methadone-Maintenance Treatment","enrollment":14},{"nctId":"NCT00933283","phase":"PHASE1","title":"A Study to Investigate the Potential Interaction Between Telaprevir and Methadone, at Steady-State","status":"COMPLETED","sponsor":"Tibotec BVBA","startDate":"2009-07","conditions":"Healthy Participants","enrollment":18},{"nctId":"NCT00879996","phase":"PHASE4","title":"Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2009-04","conditions":"Opiate Addiction","enrollment":54},{"nctId":"NCT01582425","phase":"PHASE1","title":"Drug Interaction Study of Isavuconazole and Methadone","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2012-04","conditions":"Pharmacokinetics of Isavuconazole, Pharmacokinetics of Methadone, Healthy Volunteers","enrollment":24},{"nctId":"NCT01467518","phase":"PHASE1","title":"Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2011-12","conditions":"Infections, Human Immunodeficiency Virus and Hepatitis","enrollment":11},{"nctId":"NCT01210079","phase":"PHASE2","title":"Hyperalgesia in Methadone-Maintained Patients: Can it be Treated?","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2002-09","conditions":"Opioid-Induced Hyperalgesia","enrollment":26},{"nctId":"NCT00204243","phase":"PHASE2","title":"Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services","status":"COMPLETED","sponsor":"University of Oslo","startDate":"2005-05","conditions":"Opiate Addiction","enrollment":46},{"nctId":"NCT01099748","phase":"PHASE1","title":"Estimate The Effect Of Lersivirine On The Pharmacokinetics Of S- And R-Methadone","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-05","conditions":"Healthy Volunteers","enrollment":13},{"nctId":"NCT01021566","phase":"PHASE3","title":"Opiate Detoxification Using the Combined Hemoperfusion-hemodialysis","status":"UNKNOWN","sponsor":"First People's Hospital of Foshan","startDate":"2009-11","conditions":"Opiate Addiction","enrollment":60},{"nctId":"NCT00750217","phase":"PHASE4","title":"Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches","status":"UNKNOWN","sponsor":"Psychiatric University Hospital, Zurich","startDate":"2008-08","conditions":"Heroin Addiction","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":84,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dose Taken"],"phase":"phase_2","status":"active","brandName":"Daily Methadone Dose","genericName":"Daily Methadone Dose","companyName":"Cari Health Inc.","companyId":"cari-health-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methadone is a small molecule used to treat opioid dependence and withdrawal syndrome, as well as substance-related disorders. It is administered as part of a therapeutic regimen, often in conjunction with other interventions such as lofexidine or a therapeutic workplace.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}